- Home
- ERNA vs SEED Comparison
ERNA vs SEED Comparison
Compare ERNA & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERNA | SEED |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 8.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ERNA | SEED |
|---|---|---|
| Price | $0.40 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 72.0K | 28.5K |
| Earning Date | 11-07-2025 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,000.00 | ★ $12,823,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.67 | $0.74 |
| 52 Week High | $5.55 | $2.70 |
Technical Indicators
Market Signals| Indicator | ERNA | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 24.09 | 36.61 |
| Support Level | $1.12 | $1.17 |
| Resistance Level | $1.28 | $1.36 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 0.00 | 3.85 |
Price Performance
Historical ComparisonAbout ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.